Head-To-Head Review: Tilray Brands (NASDAQ:TLRY) & Trulieve Cannabis (NYSE:TRLV)

Trulieve Cannabis (NYSE:TRLV) and Tilray Brands (NASDAQ:TLRY) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

Profitability

This table compares Trulieve Cannabis and Tilray Brands’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Trulieve Cannabis	-41.55%	-4.24%	-1.72%
Tilray Brands	-13.11%	-7.76%	-5.59%

Earnings & Valuation

This table compares Trulieve Cannabis and Tilray Brands”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trulieve Cannabis	$1.14 billion	1.80	-$116.38 million	$0.11	96.86
Tilray Brands	$210.48 million	2.24	-$121.40 million	($1.08)	-3.21

Trulieve Cannabis has higher revenue and earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Trulieve Cannabis, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

9.4% of Tilray Brands shares are owned by institutional investors. 3.8% of Trulieve Cannabis shares are owned by insiders. Comparatively, 1.6% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Trulieve Cannabis and Tilray Brands, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Trulieve Cannabis	1	1	1	0	2.00
Tilray Brands	2	2	3	1	2.38

Trulieve Cannabis currently has a consensus price target of $15.00, indicating a potential upside of 40.78%. Tilray Brands has a consensus price target of $6.38, indicating a potential upside of 83.98%. Given Tilray Brands’ stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Trulieve Cannabis.

About Trulieve Cannabis

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.

About Tilray Brands

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.